Perspective: A Precision Medicine Approach to Clinical Trials (note reference to patients/Facebook)

Cancer Biomarkers | JAMA

 “They say, ‘Dr Hong, I want to be in this trial,’” said Hong, deputy chair of the department of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. “Patients are incredibly savvy. Especially if they have end-stage cancer and their doctor has told them, ‘there’s nothing more I can do for you,’ they will find a trial.”